8-K: Surgery Partners Subsidiary Issues $425M Senior Notes

Surgery Center Holdings, a wholly-owned subsidiary of Surgery Partners, Inc., has issued an additional $425 million in 7.250% Senior Notes due 2032.

Summary

• Surgery Center Holdings, Inc., a wholly-owned subsidiary of Surgery Partners, Inc., issued an additional $425.0 million aggregate principal amount of 7.250% Senior Notes due 2032.
• These new Notes will be treated as a single series with the existing $800.0 million outstanding 7.250% Senior Notes due 2032, issued on April 10, 2024, sharing the same terms and CUSIP number.
• The Issuer expects the new Notes and the existing Notes to be fungible for U.S. federal income tax purposes, with Regulation S issued Notes trading separately under a different CUSIP for 40 days.
• The issuance was formalized through a Third Supplemental Indenture, dated December 16, 2025, with Wilmington Trust, National Association, as trustee.
• Interest on the Additional Senior Notes will accrue from October 15, 2025, with the first interest payment date scheduled for April 15, 2026.
• The Notes are guaranteed by direct and indirect subsidiaries of Surgery Center Holdings, Inc.

Sentiment

Score: 5

Explanation: The filing is a factual report of a debt issuance, which is a neutral financial event. It does not contain information that would significantly sway sentiment positively or negatively without further context on the use of proceeds or the company's overall financial strategy.

Positives

• Secured additional capital of $425.0 million through debt issuance, which can be used for general corporate purposes or other strategic initiatives.

Negatives

• Increased the company's total debt burden by $425.0 million, leading to higher interest expenses.

Risks

• Creation of a direct financial obligation for Surgery Center Holdings, Inc. and its guarantors, increasing leverage.
• Holders of Notes waive and release personal liability against directors, officers, employees, incorporators, members, partners, or equityholders of the Issuer or its Subsidiaries or Affiliates for obligations under the Notes or Indenture.

Future Outlook

The filing details the terms of the newly issued senior notes, including their interest rate, maturity date, and fungibility with existing notes. No specific forward-looking statements or guidance regarding company performance or strategic direction were provided beyond the debt instrument's terms.

Industry Context

This announcement is a company-specific financing event. The filing does not provide sufficient information to analyze its relation to broader industry trends or competitors within the healthcare services sector.

Stakeholder Impact

• Shareholders: Increased financial leverage and potential impact on earnings per share due to higher interest expense.
• Creditors (new noteholders): Investment in senior unsecured debt with a fixed interest rate of 7.250% and a maturity of 2032, guaranteed by the Issuer's subsidiaries.
• Creditors (existing noteholders): The new notes will be treated as a single series with existing notes, maintaining fungibility and equal terms.

Next Steps

• Semi-annual interest payments on the Notes will commence on April 15, 2026, and continue every April 15 and October 15 until maturity.
• The Notes will mature on April 15, 2032.

Key Dates

Keywords

Surgery Partners, Senior Notes, Debt Issuance, Corporate Finance, Bonds, Healthcare, SEC Filing, 8-K